Sign in
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
Journal article   Open access  Peer reviewed

Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?

Ebtisam Alharbi, Yojana Gadiya, David Henderson, Andrea Zaliani, Alejandra Delfin-Rossaro, Anne Cambon-Thomsen, Manfred Kohler, Gesa Witt, Danielle Welter, Nick Juty, …
Drug discovery today, Vol.27(8), pp.2080-2085
01/08/2022
PMID: 35595012

Abstract

Cost–benefit Drug discovery FAIR FAIRification Pharmaceutical R&D
url
https://doi.org/10.1016/j.drudis.2022.05.010View
Published (Version of record) Open

Metrics

1 Record Views

Details